Here's Won't Touch Teva: Why I Pass on the Generic Giant
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Compare Sp500 vs Total Market diversification for retirement to understand which approach offers broader exposure and simpler rebalancing in long-term portfolios.
28,421 articlesTeva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Greg Abel, seen as Warren Buffett's successor, made a bold move by trimming UnitedHealth from Berkshire's portfolio. ...
Lemonade is betting big on AI to transform how people buy insurance and file claims. This article digs into what lemo...
NetApp stunned traders with a dramatic Friday rally after a stronger-than-expected earnings report. This guide breaks...
Nu Holdings stands at a pivotal moment in 2026. This piece breaks down three catalysts that could send Nu stock soari...
The SEC is signaling a shift in how ETFs operate, potentially opening doors for crypto investments. This guide explai...
As markets rally into mid-2026, analysts spotlight five stock setups where Wall Street sees the most upside, driven b...
When a big shareholder starts selling, the market pays attention. This article explains what this major investor dump...
As markets climb in 2026, investors are embracing purpose-driven planning. Experts say writing your obituary help can...
Teva has climbed more than 100% in the last year, and analysts remain cautiously optimistic. Here’s why wall street t...
Canada's online brokerage scene is evolving as fee cuts and wider cross-border access reshape investor options. Here ...
A senior strategist has a bold projection for the S&P 500, arguing the index could reach 8,500 by end-2027 as a geopo...